Jürg Pfister
Founder at Theron Pharmaceuticals, Inc.
Jürg Pfister active positions
| Companies | Position | Start | End |
|---|---|---|---|
Theron Pharmaceuticals, Inc.
 Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Director/Board Member | 01/01/2008 | - |
| Founder | 01/01/2008 | - |
Career history of Jürg Pfister
Former positions of Jürg Pfister
| Companies | Position | Start | End |
|---|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Corporate Officer/Principal | - | - |
| Syntex, Inc. | Corporate Officer/Principal | - | - |
| ARYX THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Roche Bioscience
 Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | - | - |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Training of Jürg Pfister
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistics
International
| United States | 6 |
| Canada | 2 |
| Switzerland | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 6 |
| Miscellaneous | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ARYX THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Theron Pharmaceuticals, Inc.
Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Health Technology |
CoMentis, Inc.
CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Bioscience
Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Health Technology |
| Syntex, Inc. | Miscellaneous |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Jürg Pfister
- Experience
